KF
TOVX icon

Krilogy Financial’s Theriva Biologics TOVX Stock Holding History

Krilogy Financial’s Portfolio TOVX Stock Details TOVX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Hold
0
– – – 629
2018
Q3 		– Hold
0
– – – 832
2018
Q2 		– Hold
0
– – – 584
2018
Q1 		– Hold
0
– – – 815
2017
Q4 		– Hold
0
– – – 747
2017
Q3 		– Hold
0
– – – 784
2017
Q2 		– Hold
0
– – – 703
2017
Q1 		– Hold
0
– – – 691
2016
Q4 		– Hold
0
– – – 691
2016
Q3 		– Hold
0
– – – 676
2016
Q2 		– Hold
0
– – – 689
2016
Q1 		– Hold
0
– – – 615
2015
Q4 		– Hold
0
– – – 384
2015
Q3 		– Hold
0
– – – 555

Other funds holding TOVX

SM
Sabby Management Miami Beach, Florida $111M AUM 74.4% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
TS
Third Security Radford, Virginia $241M AUM 45.43% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
AFM
Anson Funds Management Dallas, Texas $1.68B AUM 373.57% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.6B AUM 109.3% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $38.4B AUM 25.71% 1-Year Est. Return
6CM
683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return